Contract: GLAXOSMITHKLINE LLC
Primary Recipient
GLAXOSMITHKLINE LLC
Amount
$62,478,417.00
Award Date
9/28/2009
Administering Agency
Health and Human Services, Department of
CDFA Number
CDFA Program Title
Description
Perform studies under Antigen Sparing contract relating to H1N1 and other strains of pandemic influenza vaccine.
Recipients Connected to Award
| Recipient | Role | Amount |
|---|---|---|
| GLAXOSMITHKLINE LLC | Primary recipient | $58,476,265.01 |
| PPD DEVELOPMENT, LP | Sub-recipient | $1,292,220.31 |
| ACCELOVANCE, INC. | Sub-recipient | $677,331.00 |
| UNIVERSITY OF MASSACHUSETTS | Sub-recipient | $394,573.00 |
| MCVEIGH ASSOCIATES, LTD. | Sub-recipient | $358,589.68 |
| Clinical Resource Network, LLC | Sub-recipient | $305,910.00 |
| VERISTAT, INC | Sub-recipient | $298,800.00 |
| Ingenix Pharmaceutical Services, Inc. | Sub-recipient | $297,270.00 |
| CHESAPEAKE RESEARCH REVIEW, INC. | Sub-recipient | $191,410.00 |
| MCLAUGHLIN B ASSOCIATES INC | Sub-recipient | $186,048.00 |